Cetuximab+RT found to be inferior to standard treatment in HPV+ oropharyngeal cancer
Credit: National Cancer Institute An interim analysis of data from a randomized clinical trial of patients with human papillomavirus (HPV)-positive oropharyngeal cancer found that treatment...










